Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date

Beck KM, Sanchez IM, Yang EJ, Liao W

Psoriasis: Targets and Therapy 2018, 8:49-58

Published Date: 29 August 2018